Holistic Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-522
Closed -$302K 151
2025
Q4
$302K Sell
522
-27
-5% -$15.3K 0.11% 94
2025
Q3
$266K Buy
+549
New +$256K 0.11% 110
2023
Q2
Sell
-358
Closed -$206K 112
2023
Q1
$206K Buy
+358
New +$202K 0.16% 96
2022
Q2
Sell
-382
Closed -$226K 117
2022
Q1
$226K Sell
382
-94
-20% -$54K 0.14% 93
2021
Q4
$318K Buy
476
+37
+8% +$23.1K 0.18% 82
2021
Q3
$251K Buy
+439
New +$241K 0.15% 90
2018
Q2
Sell
-185
Closed -$38K 329
2018
Q1
$38K Buy
185
+5
+3% +$1.05K 0.03% 225
2017
Q4
$34K Buy
+180
New +$34.5K 0.03% 242

Other funds holding TMO

Holistic Financial Partners's TMO Position: Q1 2026 in Review

Holistic Financial Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 522 shares — an estimated $302K sold.

Holistic Financial Partners first reported a position in TMO in Q4 2017 and held it in 8 quarters. The position peaked at $318K in Q4 2021. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Holistic Financial Partners reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Holistic Financial Partners sold 522 Thermo Fisher Scientific shares in Q1 2026, an estimated $302K.
  • Holistic Financial Partners first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 8 quarters.
  • Holistic Financial Partners's Thermo Fisher Scientific position peaked at $318K in Q4 2021.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Holistic Financial Partners's 13F filing for Q1 2026, filed 5 May 2026.